A New Day: The Role of Telemedicine in Reshaping Care for Persons with Movement Disorders

被引:34
作者
Dorsey, E. Ray [1 ]
Bloem, Bastiaan R. [2 ,3 ,4 ]
Okun, Michael S. [5 ]
机构
[1] Univ Rochester, Med Ctr, Dept Neurol, Ctr Hlth Technol, 265 Crittenden Blvd,CU 420694, Rochester, NY 14642 USA
[2] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[3] Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands
[4] Ctr Expertise Parkinson & Movement Disorders, Nijmegen, Netherlands
[5] Univ Florida, Dept Neurol, Fixel Inst Neurol Dis, Program Movement Disorders & Neurorestorat, Gainesville, FL USA
基金
美国国家卫生研究院;
关键词
telemedicine; Parkinson's disease; movement disorders; patient-centered care; delivery of health care; COVID-19; PARKINSONS-DISEASE; PATIENT SATISFACTION; NURSING-HOME; PREVALENCE; POPULATION; MANAGEMENT; FUTURE; MODEL;
D O I
10.1002/mds.28296
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The COVID-19 pandemic has demonstrated the fragility of clinic-based care for Parkinson's disease and other movement disorders. In response to the virus, many clinics across the world abruptly closed their doors to persons with Parkinson's disease. Fortunately, a niche care model, telemedicine-first described in this journal a generation ago-emerged as the dominant means of providing care. As we adjust to a new normal, we should focus future care not on clinics but on patients. Their needs, guided by clinicians, should determine how care is delivered, whether in the clinic, at home, remotely, or by some combination. Within this patient-centered approach, telemedicine is an attractive care option but not a complete replacement for in-person consultations, which are valuable for specific problems and for those who have access. Now that many clinicians and patients have gained exposure to telemedicine, we can better appreciate its advantages (eg, convenience) and disadvantages (eg, restricted examination). We can also create a new future that utilizes the Internet, video conferencing, smartphones, and sensors. This future will bring many clinicians to one patient, connect individual experts to countless patients, use widely available devices to facilitate diagnosis, and apply novel technologies to measure the disease in new ways. These approaches, which extend to education and research, enable a future where we can care for anyone anywhere and will help us stem the tide of Parkinson's disease. (c) 2020 International Parkinson and Movement Disorder Society
引用
收藏
页码:1897 / 1902
页数:6
相关论文
共 50 条
  • [31] The Evolving Role of Diffusion Magnetic Resonance Imaging in Movement Disorders
    Christopher W. Hess
    Edward Ofori
    Umer Akbar
    Michael S. Okun
    David E. Vaillancourt
    Current Neurology and Neuroscience Reports, 2013, 13
  • [32] Wearable devices for gait and posture monitoring via telemedicine in people with movement disorders and multiple sclerosis: a systematic review
    Salaorni, Francesca
    Bonardi, Giulia
    Schena, Federico
    Tinazzi, Michele
    Gandolfi, Marialuisa
    EXPERT REVIEW OF MEDICAL DEVICES, 2024, 21 (1-2) : 121 - 140
  • [33] Access and Attitudes Toward Palliative Care Among Movement Disorders Clinicians
    Miyasaki, Janis M.
    Lim, Shen-Yang
    Chaudhuri, K. Ray
    Antonini, Angelo
    Piemonte, Maria
    Richfield, Edward
    Alburquerque Gonzalez, Daniela
    Lorenzl, Stefan
    Walker, Richard
    Bhidayasiri, Roongroj
    Bouca, Raquel
    McConvey, Victor
    MOVEMENT DISORDERS, 2022, 37 (01) : 182 - 189
  • [34] Editorial: Patient Empowerment and Person-Centered Care in Movement Disorders
    Ramirez-Zamora, Adolfo
    Chana, Pedro
    Rodriguez-Violante, Mayela
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [35] Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease
    Poonja, Sabrina
    Chaudhuri, K. Ray
    Miyasaki, Janis M.
    CURRENT OPINION IN NEUROLOGY, 2022, 35 (04) : 494 - 501
  • [36] An update on new and unique uses of botulinum toxin in movement disorders
    Jankovic, Joseph
    TOXICON, 2018, 147 : 84 - 88
  • [37] Phenomenological patterns and aetiological spectrum in patients visiting a tertiary care Movement disorders service in India: An observational study
    Kumar, Niraj
    Desai, Ishita
    Kumar, Mritunjai
    Singh, Jagbir
    Tiwari, Ashutosh
    Dhar, Nikita
    Madhaw, Govind
    Manchanda, Rajat
    Jatale, Vinayak
    Radhakrishnan, Divya M.
    Warrier, Anand R.
    Shree, Ritu
    Kumari, Sweety
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 245
  • [38] Is There a Role for DAT-SPECT Imaging in a Specialty Movement Disorders Practice?
    Bega, Danny
    Gonzalez-Latapi, Paulina
    Zadikoff, Cindy
    Spies, William
    Simuni, Tanya
    NEURODEGENERATIVE DISEASES, 2015, 15 (02) : 81 - 86
  • [39] The Legacy of Charles David Marsden: A Role Model in the Field of Movement Disorders
    Borges de Macedo Zubko, Luis Eduardo
    Pedro Franco, Matheus Kahakura
    Meira, Alex Tiburtino
    Branco Germiniani, Francisco Manoel
    Ferreira Camargo, Carlos Henrique
    Ghizoni Teive, Helio Afonso
    EUROPEAN NEUROLOGY, 2019, 81 (5-6) : 319 - 322
  • [40] New Imaging Markers for Movement Disorders
    Ghadery, Christine
    Strafella, Antonio P.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (05)